Merck for Mothers Launches New Report: Innovative Financing For Better Maternal Health Outcomes

Jan 24, 2020 11:55 AM ET

The cost to end preventable maternal deaths by 2030 is an estimated $115.5 billion, according to the United Nations Population Fund. With just $11.9 billion in development assistance coming to 120 priority countries over the next 10 years, that leaves a $103.4 billion investment gap. 

To help close this gap, Merck for Mothers is driving new thinking and new action in health financing – with the aim of scaling promising solutions for better maternal health. Discover the latest report from our All for Mothers series to see how we can advance progress toward SDG targets and beyond through innovative financing. Learn more here.

All for Mothers elevates the voices of mothers, global healthcare leaders and advocates in order to highlight the most vital work being done to end maternal mortality around the world.

Merck for Mothers is Merck’s $500 million initiative to help create a world where no woman has to die giving life. Applying Merck’s business and scientific resources, we collaborate with partners to improve the health and well-being of women during pregnancy, childbirth and the postpartum period. Merck for Mothers is known as MSD for Mothers outside the United States and Canada.